Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?

Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based drug in cancer treatment. We discuss the development of this innovative compound and report the recent changing-practice results in breast and pancreatic cancer. A ground-breaking finding is the demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cucinotto, Iole, Fiorillo, Lucia, Gualtieri, Simona, Arbitrio, Mariamena, Ciliberto, Domenico, Staropoli, Nicoletta, Grimaldi, Anna, Luce, Amalia, Tassone, Pierfrancesco, Caraglia, Michele, Tagliaferri, Pierosandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659516/
https://www.ncbi.nlm.nih.gov/pubmed/23738077
http://dx.doi.org/10.1155/2013/905091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659516/
https://www.ncbi.nlm.nih.gov/pubmed/23738077
http://dx.doi.org/10.1155/2013/905091

Ejemplares similares